In addition, decreased DUSP9 level was closely associated with larger tumors, deeper invasion, and advanced cancer stage, indicating that DUSP9 down-regulation is associated with tumor progression and poor prognosis in CRC [56]. This evidence concerns the gene DUSP9 and colorectal carcinoma.